Recent Finacing
Recent Raise
Edimer Pharmaceuticals is a Cambridge-based biotech developing EDI200, a recombinant EDA‑A1 replacement protein for XLHED, conducting preclinical and clinical programs including neonatal and Phase 2 trials and patient recruitment.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors